Cortisol and Thyroid Conversion: What the Studies Actually Measure
Cortisol and thyroid-hormone metabolism are connected, but the relationship depends on the experimental setting. Drug exposure, an exercise stress test and ordinary day-to-day stress are not interchangeable. The most useful question is whether a study measured thyroid-hormone conversion itself—or a separate outcome such as cortisol, fatigue or sleep.
What the thyroid-conversion experiments show
In a 1984 experiment, male Sprague-Dawley rats underwent thyroid removal and received T4 replacement at 1.6 micrograms per day per 100 g body weight through a subcutaneous osmotic minipump. During the final five days, dexamethasone was delivered by minipump at 0.15 mg per day per 100 g body weight. The fraction of administered T4 converted to T3 fell from 0.21 in controls to 0.11 with dexamethasone. Serum T3 concentrations were nevertheless similar between groups, illustrating that production, clearance and tissue distribution can change together. [1]
A later study in cultured rat liver and kidney cells produced a different result. Dexamethasone increased type 1 deiodinase expression and activity; in liver cells, enzyme activity rose by 128 ± 6%. The authors concluded that their findings did not support direct glucocorticoid inhibition of this enzyme as the explanation for nonthyroidal illness. [2]
These findings are not a simple contradiction to be discarded: an intact animal and an isolated cell system answer different questions. Together, they show why a single pathway diagram cannot establish that psychological stress causes a particular low-T3 pattern—or that lowering cortisol will correct it.
Selenium: enzyme biology does not establish a supplement dose
Selenium participates in proteins involved in thyroid-hormone synthesis and metabolism. That biological role makes selenium status relevant, but does not mean that additional selenium necessarily raises T3.
The Danish DK-PRECISE trial randomized 491 adults aged 60–74 to selenium-enriched yeast tablets supplying 100, 200 or 300 micrograms daily, or placebo. Thyroid measurements were assessed after six months and five years; 361 participants completed the five-year intervention. Supplementation produced small reductions in TSH and free T4, but no significant change in free T3 or the free-T3-to-free-T4 ratio. These results in euthyroid adults do not validate a 400-microgram daily “conversion support” protocol. [3]
Human stress studies: useful findings, different endpoints
Phosphatidylserine
A double-blind crossover study enrolled 10 healthy men who ingested phosphatidylserine 600 mg/day or placebo for 10 days. Following a 15-minute cycling test, mean peak cortisol and cortisol area under the curve were approximately 39% and 35% lower, respectively, with phosphatidylserine. Growth hormone and lactate were not affected. This was an acute exercise-response study, not a trial of thyroid recovery or an eight-week combined regimen. [4]
Rhodiola rosea
In 60 adults aged 20–55 with stress-related fatigue, the standardized SHR-5 extract was studied as four tablets providing 576 mg/day for 28 days. Compared with placebo, it improved the burnout score and selected attention measures and altered the cortisol response to awakening. Both groups improved on several measures, so the findings should not be described as uniformly positive across every outcome. The tested extract and exposure also differ from 200 mg daily for two weeks. [5]
Vitamin C
A study of 69 women with elevated cortisol and/or DHEA-S compared oral vitamin C at 1,000 mg/day with unchanged diet over two months. Among supplemented women in the elevated-cortisol-only group, mean cortisol fell from 780 ± 57 to 446 ± 26 nmol/L. The comparison was not a blinded placebo intervention, and the reported outcomes were cortisol and DHEA-S—not restored T4-to-T3 conversion. The studied daily dose was half of a schedule using 1,000 mg twice daily. [6]
Omega-3 fatty acids
A randomized trial in 138 sedentary, overweight, middle-aged adults tested oral omega-3 supplementation at 1.25 or 2.5 g/day for four months. During a laboratory speech stressor, the 2.5-g group had 19% lower overall cortisol and 33% lower IL-6 geometric mean levels than placebo. These stress-response findings do not establish thyroid recovery or support treating a 4-g daily regimen as the same intervention. [7]
Morning light can raise cortisol rather than suppress it
In a controlled study, eight healthy men remained awake for 36 hours under different light conditions. A three-hour bright-light exposure from 05:00 to 08:00 produced an immediate cortisol increase of more than 50%, suppressed melatonin and reduced deterioration in alertness. No effect on TSH profiles was detected. Afternoon bright light did not produce the same responses. [8]
This is evidence that timing matters. It is not evidence that cortisol should always be lower, nor that 20 minutes outdoors at a fixed clock time restores thyroid conversion. The sleep-deprivation setting and three-hour laboratory exposure must remain attached to the result.
Where sleep and peptide research fit
Sleep quality, anxiety, inflammatory signalling and thyroid function are separate endpoints. A study reporting improvement in one does not automatically demonstrate improvement in another. The research reviewed here does not test the proposed combination of Selank, DSIP, Epitalon, KPV and BPC-157 as a thyroid-restoration regimen.
For related background, our KPV research article covers inflammatory signalling. Those findings should be read in their own models, without treating reduced inflammation as a measured increase in thyroid-hormone conversion.
What would establish thyroid recovery?
A convincing intervention study would need a defined population, a control group, specified exposures, thyroid outcomes measured before and after treatment, and adverse-event reporting. Cortisol changes alone would not establish success. Neither would improved sleep, a lower fatigue score or a plausible mechanism assembled from unrelated experiments.
This is a different question from why retatrutide weight loss can plateau. The article here examines what the cortisol and conversion experiments actually measured; our guide to reading peptide research explains how to distinguish those endpoints from treatment claims.